Machine Learning-based Classification of Symptom Clusters and Online CBT
1 other identifier
interventional
380
1 country
1
Brief Summary
To breakthrough the bottleneck identified, we will conduct a cross-sectional study to develop a symptom clustering model for depression and anxiety. A wide range of statistical methods as well as machine learning approaches were explored, and a cohesive hierarchical clustering algorithm will be used. After developing the model, a symptom-matched intervention program based on problem solving therapy will be formulated. We are supposed to examine whether its use for personalizing symptom-matched psychological treatment can lead to improved patient outcomes, compared with usual care. This project is expected to provide a new and precise method for the emotion management, which will provide a standardized intervention pathway combining screening with treatment for the management of depression symptom and anxiety symptom. A preciser intervention matched to individual symptoms may provide important insight in improving patient outcome as well as a standardized mood management pathway targeting to the early detection and intervention for community residents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJanuary 8, 2026
January 1, 2026
8 months
April 1, 2024
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Patient Health Questionnaire (PHQ-9)
Baseline, week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 12, week 20, week 32
GAD-7
Baseline, week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 12, week 20, week 32
Secondary Outcomes (3)
PSQI
Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32
WHODAS 2.0
Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32
EQ-5D-5L
Baseline, week 1, week 4, week 6, week 8, week 12, week 20, week 32
Other Outcomes (2)
remission rate
week 8, week 12, week 20, week 32
SBQ-R
week -1 pre-screening
Study Arms (2)
8 weeks Problem-solving therapy
EXPERIMENTALProblem-solving therapy imparts problem-solving abilities applicable to participants' daily lives. Personalized therapies, including brief behavioral treatment of insomnia, mindfulness, and physical exercise suggestions, were tailored to correspond with patients' specific clusters of sadness and anxiety symptoms.
treatment as usual
PLACEBO COMPARATORCare as usual with the PST-PC learning manual and generic information from the same domains (BBTI, mindfulness, and physical activity) included in the intervention group's daily check-ins
Interventions
Problem-solving therapy-based holistic emotion management interventions matched to individual symptoms
Eligibility Criteria
You may qualify if:
- Aged between 18 and 64 years. PHQ-9 ≥10 and/or GAD-7 ≥8 at baseline assessment defined as the threshold for caseness.
You may not qualify if:
- People will be excluded if they meet any of the following criteria:
- They are receiving psychological therapy during an interview for any mental health issue;
- currently acutely suicidal or have attempted suicide in the past 2 months, as indicated by PHQ-9 item 9;
- cognitively impaired or diagnosed with bipolar disorder or psychosis or experiencing psychotic symptoms; d) dependent on alcohol or drugs; e) living with an unstable or acute medical illness that would interfere with trial participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renmin Hospital of Wuhan University
Wuhan, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2024
First Posted
April 5, 2024
Study Start
September 1, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share